|
|||||
|
|
A randomized double-blind,placebo-controlled study of omalizumab for idiopathic anaphylaxis |
|
| Authors: | Melody C. Carter Irina Maric Erica H. Brittain Yun Bai Keith Lumbard Hyejeong Bolan Daly Cantave Linda M. Scott Dean D. Metcalfe |
| Affiliation: | 1. Mast Cell Biology Section, Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md;2. Hematology Section, Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md;3. Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda; Md;4. Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Md;5. Department of Nursing, Clinical Center, National Institutes of Health, Bethesda, Md |
| Abstract: | |
| Keywords: | Idiopathic anaphylaxis omalizumab randomized therapy DBPC" },{" #name" :" keyword" ," $" :{" id" :" kwrd0035" }," $$" :[{" #name" :" text" ," _" :" Double-blind, placebo-controlled IA" },{" #name" :" keyword" ," $" :{" id" :" kwrd0045" }," $$" :[{" #name" :" text" ," _" :" Idiopathic anaphylaxis NIH" },{" #name" :" keyword" ," $" :{" id" :" kwrd0055" }," $$" :[{" #name" :" text" ," _" :" National Institutes of Health |
| 本文献已被 ScienceDirect 等数据库收录！ | |